相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation
Belinda S. Hall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Cysteine cathepsins: From structure, function and regulation to new frontiers
Vito Turk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
The peptidases of Trypanosoma cruzi: Digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death
Vanina E. Alvarez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
Shane R. Wilkinson et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Pharmacokinetics and Metabolism in Rats, Dogs, and Monkeys of the Cathepsin K Inhibitor Odanacatib: Demethylation of a Methylsulfonyl Moiety as a Major Metabolic Pathway
Kelem Kassahun et al.
DRUG METABOLISM AND DISPOSITION (2011)
Methodological advances in drug discovery for Chagas disease
Juan M. Bustamante et al.
EXPERT OPINION ON DRUG DISCOVERY (2011)
Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites
Belinda S. Hall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis
Robert T. Jacobs et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
The Trypanosoma cruzi Protease Cruzain Mediates Immune Evasion
Patricia S. Doyle et al.
PLOS PATHOGENS (2011)
Aziridine-2,3-Dicarboxylate-Based Cysteine Cathepsin Inhibitors Induce Cell Death in Leishmania major Associated with Accumulation of Debris in Autophagy-Related Lysosome-Like Vacuoles
Uta Schurigt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The discovery of MK-0674, an orally bioavailable cathepsin K inhibitor
Elise Isabel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease
Christian Beaulieu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
α-Ketoheterocycles as Inhibitors of Leishmania mexicana Cysteine Protease CPB
Koen Steert et al.
CHEMMEDCHEM (2010)
Chagas Disease: Progress and New Perspectives
F. Sanchez-Sancho et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Trypanosomatid Parasites Causing Neglected Diseases
K. Nussbaum et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Hurdles in the Drug Discovery of Cathepsin K Inhibitors
Motohiko Kometani et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Proteolytic cleavage of chemokines by Trypanosoma cruzi's cruzipain inhibits chemokine functions by promoting the generation of antagonists
I. Benitez-Hernandez et al.
IMMUNOBIOLOGY (2010)
Nonpeptidic Tetrafluorophenoxymethyl Ketone Cruzain Inhibitors as Promising New Leads for Chagas Disease Chemotherapy
Katrien Brak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas
Jean-Claude Dujardin et al.
TRENDS IN PARASITOLOGY (2010)
Development of second generation amidinohydrazones, thio- and semicarbazones as Trypanosoma cruzi-inhibitors bearing benzofuroxan and benzimidazole 1,3-dioxide core scaffolds
Alicia Merlino et al.
MEDCHEMCOMM (2010)
Leishmania donovani Isolates with Antimony-Resistant but Not -Sensitive Phenotype Inhibit Sodium Antimony Gluconate-Induced Dendritic Cell Activation
Arun Kumar Haldar et al.
PLOS PATHOGENS (2010)
Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors
Michael J. Boyd et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases
Clifford Bryant et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Changes in Trypanosoma cruzi-Specific Immune Responses after Treatment: Surrogate Markers of Treatment Efficacy
Susana A. Laucella et al.
CLINICAL INFECTIOUS DISEASES (2009)
Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies
S. A. Stoch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Approaches for the Development of New Anti-Trypanosoma cruzi Agents
Diogo Rodrigo Magalhaes Moreira et al.
CURRENT DRUG TARGETS (2009)
Cruzipain, the Major Cysteine Protease of Trypanosoma cruzi: A Sulfated Glycoprotein Antigen as Relevant Candidate for Vaccine Development and Drug Target. A Review
Vilma G. Duschak et al.
CURRENT MEDICINAL CHEMISTRY (2009)
New Therapeutic Targets for Drug Design Against Trypanosoma cruzi, Advances and Perspectives
Gildardo Rivera et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Trypanosoma cruzi targets for new chemotherapeutic approaches
Maria Nazare C. Soeiro et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Proteolytic generation of kinins in tissues infected by Trypanosoma cruzi depends on CXC chemokine secretion by macrophages activated via Toll-like 2 receptors
Veronica Schmitz et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
On-Bead Screening of a Combinatorial Fumaric Acid Derived Peptide Library Yields Antiplasmodial Cysteine Protease Inhibitors with Unusual Peptide Sequences
Uwe Machon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Kinetoplastid papain-like cysteine peptidases
Conor R. Caffrey et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2009)
Two approaches to discovering and developing new drugs for Chagas disease
J. H. McKerrow et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Regulatory Elements within the Prodomain of Falcipain-2, a Cysteine Protease of the Malaria Parasite Plasmodium falciparum
Kailash C. Pandey et al.
PLOS ONE (2009)
New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients
Isabela Ribeiro et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K
Jacques Yves Gauthier et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Real-Time In Vivo Green Fluorescent Protein Imaging of a Murine Leishmaniasis Model as a New Tool for Leishmania Vaccine and Drug Discovery
Sanjay R. Mehta et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Identification of the major cysteine protease of Giardia and its role in encystation
Kelly N. DuBois et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease
Juan M. Bustamante et al.
NATURE MEDICINE (2008)
A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes
Shane R. Wilkinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Effect of cathepsin K inhibitor basicity on in vivo off-target activities
Sylvie Desmarais et al.
MOLECULAR PHARMACOLOGY (2008)
A role for protease activity and host-cell permeability during the process of Trypanosoma cruzi egress from infected cells
Jaime Costales et al.
JOURNAL OF PARASITOLOGY (2007)
A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection
Patricia S. Doyle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?
Francois Chappuis et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Cwp84, a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins
Claire Janoir et al.
JOURNAL OF BACTERIOLOGY (2007)
A generally applicable method for assessing the electrophilicity and reactivity of diverse nitrile-containing compounds
Renata M. Oballa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The consequences of lysosomotropism on the design of selective cathepsin K inhibitors
W. Cameron Black et al.
CHEMBIOCHEM (2006)
A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi
SC Barr et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity
JP Falgueyret et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K
WC Black et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Comparative genomics of trypanosomatid parasitic protozoa
NM El-Sayed et al.
SCIENCE (2005)
Development of α-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease
Y Choe et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain
N Fujii et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes
IM Aparicio et al.
INFECTION AND IMMUNITY (2004)
Cysteine peptidases as virulence factors of Leishmania
JC Mottram et al.
CURRENT OPINION IN MICROBIOLOGY (2004)
Effect of hydrogen peroxide and other protease inhibitors on Cryptosporidium parvum excystation and in vitro development
KE Kniel et al.
JOURNAL OF PARASITOLOGY (2004)
Cysteine proteases of malaria parasites
PJ Rosenthal
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2004)
Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi
DC Greenbaum et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis
A Zadeh-Vakili et al.
VACCINE (2004)
Drug transport and drug resistance in African trypanosomes
P Mäser et al.
DRUG RESISTANCE UPDATES (2003)
Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi
P Berasain et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2003)
Improved trypanocidal activities of cathepsin L inhibitors
NJ Nkemngu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Human and parasitic papain-like cysteine proteases:: Their role in physiology and pathology and recent developments in inhibitor design
F Lecaille et al.
CHEMICAL REVIEWS (2002)
Expression in insect cells of active mature cruzipain from Trypanosoma cruzi, containing its C-terminal domain
V Alvarez et al.
PROTEIN EXPRESSION AND PURIFICATION (2002)
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs
KMM Doan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis
L Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Chemotherapy of Chagas disease
JA Urbina
CURRENT PHARMACEUTICAL DESIGN (2002)
Cysteine proteases of parasitic organisms
M Sajid et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2002)
Comparison of the specificity, stability and individual rate constants with respective activation parameters for the peptidase activity of cruzipain and its recombinant form, cruzain, from Trypanosoma cruzi
WAS Judice et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Drug resistance in Trypanosoma cruzi is not associated with amplification or overexpression of P-glycoprotein (PGP) genes
SMF Murta et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2001)
Analysis of the S2 subsite specificities of the recombinant cysteine proteinases CPB of Leishmania mexicana, and cruzain of Trypanosoma cruzi, using fluorescent substrates containing non-natural basic amino acids
LC Alves et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2001)
Subsite specificity of trypanosomal cathepsin L-like cysteine proteases -: Probing the S2 pocket with phenylalanine-derived amino acids
F Lecaille et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors
APCA Lima et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2001)
S1 subsite specificity of a recombinant cysteine proteinase, CPB, of Leishmania mexicana compared with cruzain, human cathepsin L and papain using substrates containing non-natural basic amino acids
LC Alves et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Molecular modeling and substrate specificity of discrete cruzipain-like and cathepsin L-like cysteine proteinases of the human blood fluke Schistosoma mansoni
CP Brady et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Altered expression of cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases
V Yong et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)
Cysteine proteinases and the pathogenesis of amebiasis
XC Que et al.
CLINICAL MICROBIOLOGY REVIEWS (2000)
分享论文
